Should You Buy Johnson Matthey?

I reckon precious-metals refiner and recycler Johnson Matthey  (LSE: JMAT  ) is positioned well to gain from an expected increase in precious-metal prices, a subsequent pick-up in scrap metal availability and accelerating demand for catalytic converters.

But Johnson Matthey is a classic cyclical play that has suffered from volatile metal prices and weak European car demand in recent months. Although the long-term investment case remains compelling, I for one will not be investing until signs of a recovery kick into gear.

Short-term outlook remains bleak
Johnson Matthey's January interims revealed third-quarter sales down 2% to £635 million, excluding precious-metals sales. This in turn drove underlying profit 19% lower to £84.3 million.

And the company warned that the insipid condition of the European light-vehicle and truck market is likely to keep its Emission Control Technologies sub-division under pressure -- sales here fell 6% in quarter three to £346 million.

Adding to these woes, the firm announced last week that it had lost a deal with South African platinum supplier Amplats, under which Johnson Matthey received discounts on its metal purchases. This is expected to cost the company around £35 million per year.

"Autocat" demand set to bounce higher
Despite current weakness, I believe that the prospect of rising car and truck sales across the globe should boost the catalytic-converter manufacturer over the longer term.

In spite of lasting weakness in Europe, new diesel regulations are due to be introduced in the region from next year, which should boost Johnson Matthey's 'autocatalyst' division.

Broker Liberum Capital anticipates a revenue annual growth rate from 2011 to 2015 of 25% for trucks and "non-highway" vehicle catalysts, and a reading of 10% for light-vehicle catalysts and petrochemical catalysts.

Earnings growth ready to gain traction
City analysts expect earnings per share (EPS) to dip 6%, to 145 pence, during the financial year ended March 2013. But growth is expected to rebound thereafter -- EPS is forecast to rise 7% next year to 155 pence before leaping an additional 12% in 2014 to 173 pence.

Johnson Matthey trades on a P/E ratio of 16.2 for 2013, which is anticipated to drop to 15.2 and 13.6 in 2014 and 2015 respectively. Although this is cheap compared with a forward P/E of 23.2 for the wider chemicals sector, I believe these levels remain too heady considering the still-murky near-term outlook.

The expert view to growth elsewhere
If you are looking to significantly boost your investment returns elsewhere, check out this special Fool report, which outlines the steps you might wish to take if you are hoping to become seriously rich from other shares.

Our "10 Steps to Making a Million in the Market" report highlights how fast-growth small-caps and beaten-down bargains are all fertile candidates to produce ten-fold returns. Click here nowto enjoy this exclusive "wealth report" -- it's 100% free and comes with no obligation.

link


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2272589, ~/Articles/ArticleHandler.aspx, 7/22/2014 7:50:47 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 17,113.54 61.81 0.36%
S&P 500 1,983.53 9.90 0.50%
NASD 4,456.02 31.31 0.71%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

7/22/2014 11:35 AM
JMAT $3059.00 Up +36.00 +1.19%
Johnson Matthey CAPS Rating: No stars

Advertisement